Marc Berger

5.1k total citations · 1 hit paper
98 papers, 2.0k citations indexed

About

Marc Berger is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Marc Berger has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 29 papers in Genetics and 20 papers in Physiology. Recurrent topics in Marc Berger's work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Marc Berger is often cited by papers focused on Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Marc Berger collaborates with scholars based in France, United States and United Kingdom. Marc Berger's co-authors include Chantal Rapatel, Catherine Caillaud, Jérôme Stirnemann, Nadia Belmatoug, J. Serratrice, Fabrice Camou, Thierry Billette de Villemeur, Christian Rosé, Jacques Serratrice and Anaïs Brassier and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marc Berger

94 papers receiving 1.9k citations

Hit Papers

A Review of Gaucher Disease Pathophysiology, Clinical Pre... 2017 2026 2020 2023 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
    2017 510 citations Jérôme Stirnemann, Nadia Belmatoug et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Berger France 25 706 597 542 537 306 98 2.0k
Daniel Kraft United States 13 391 0.6× 291 0.5× 330 0.6× 596 1.1× 106 0.3× 30 1.7k
Martin Champagne Canada 25 855 1.2× 328 0.5× 613 1.1× 832 1.5× 99 0.3× 59 2.5k
Arnulf Pekrun Germany 25 771 1.1× 600 1.0× 620 1.1× 812 1.5× 125 0.4× 70 2.2k
Kimberly Straley United States 16 358 0.5× 137 0.2× 470 0.9× 1.3k 2.5× 191 0.6× 25 3.1k
Yoshio Kanayama Japan 25 865 1.2× 286 0.5× 403 0.7× 946 1.8× 259 0.8× 78 3.1k
Robert Silasi‐Mansat United States 24 281 0.4× 150 0.3× 196 0.4× 594 1.1× 143 0.5× 53 1.9k
Matthew R. Warr United States 17 876 1.2× 221 0.4× 454 0.8× 1.6k 3.1× 174 0.6× 30 2.9k
Eugenio Gallo Italy 27 711 1.0× 134 0.2× 393 0.7× 687 1.3× 152 0.5× 94 2.3k
Leigh Samsel United States 26 353 0.5× 319 0.5× 247 0.5× 568 1.1× 77 0.3× 45 1.8k
Naoko Minegishi Japan 29 907 1.3× 366 0.6× 410 0.8× 1.4k 2.6× 301 1.0× 74 2.7k

Countries citing papers authored by Marc Berger

Since Specialization
Citations

This map shows the geographic impact of Marc Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Berger more than expected).

Fields of papers citing papers by Marc Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Berger. The network helps show where Marc Berger may publish in the future.

Co-authorship network of co-authors of Marc Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Berger. A scholar is included among the top collaborators of Marc Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Berger. Marc Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouillon‐Minois, Jean‐Baptiste, et al.. (2025). Contribution of molecular characterization to the diagnosis of MPN in patients with low JAK2V617F variant allelic fraction in a real-world cohort. Annals of Hematology. 104(3). 1587–1596.
2.
Lambert, Céline, Élisabeth Daguenet, Gabrielle Roth-Guépin, et al.. (2024). The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort. Haematologica. 109(9). 2893–2907. 2 indexed citations
3.
Antonio, Marie De, Victoria Cacheux, Lauren Véronèse, et al.. (2024). Faster clinical decisions in B‐cell acute lymphoblastic leukaemia: A single flow cytometric 12‐colour tube improves diagnosis and minimal residual disease follow‐up. British Journal of Haematology. 204(5). 1872–1881.
4.
Berger, Marc, et al.. (2024). A Real-World Investigation of MRI Changes in Bone in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: The EIROS Study. Journal of Clinical Medicine. 13(10). 2926–2926. 1 indexed citations
5.
Berger, Marc, Céline Lesueur, Juliette Berger, et al.. (2024). Deciphering metabolic shifts in Gaucher disease type 1: a multi-omics study. Journal of Molecular Medicine. 103(2). 187–203. 2 indexed citations
6.
7.
8.
Pons‐Rejraji, Hanae, Sandra Dollet, Céline Bourgne, et al.. (2023). Freezing Does Not Alter Sperm Telomere Length despite Increasing DNA Oxidation and Fragmentation. Genes. 14(5). 1039–1039. 4 indexed citations
9.
Bourgne, Céline, Chinmay Munje, Juliette Berger, et al.. (2022). The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia. Cancers. 14(19). 4695–4695. 3 indexed citations
10.
Arnoux, Armelle, Anaïs Brassier, Samia Pichard, et al.. (2022). Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities—the TENALYS study, a patient perspective survey. Orphanet Journal of Rare Diseases. 17(1). 68–68. 8 indexed citations
11.
Bourgne, Céline, et al.. (2021). DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model. Cancers. 13(14). 3587–3587. 10 indexed citations
12.
Brassier, Anaïs, Thierry Billette de Villemeur, Daniel Amsallem, et al.. (2017). Type 3 Gaucher disease, diagnostic in adulthood. Molecular Genetics and Metabolism Reports. 13. 1–2. 3 indexed citations
13.
Serratrice, J., Guillaume Pénaranda, Nathalie Bardin, et al.. (2016). Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects. Joint Bone Spine. 85(1). 71–77. 6 indexed citations
14.
Bourgne, Céline, Juliette Berger, Karin Tarte, et al.. (2014). The Chronic Lymphocytic Leukemia Clone Disrupts the Bone Marrow Microenvironment. Stem Cells and Development. 23(24). 2972–2982. 18 indexed citations
15.
Lebreton, Aurélien, et al.. (2011). Factor V inhibitor: case report and literature review. Annales de biologie clinique. 69(2). 217–222. 1 indexed citations
16.
Merlin, Étienne, Florence Jacomet, M. D’Incan, et al.. (2011). Use of cryopreserved autologous cells for extracorporeal photochemotherapy: clinical applications. Transfusion. 51(6). 1296–1299. 7 indexed citations
17.
Hughes, Derralynn, Maria Domenica Cappellini, Marc Berger, et al.. (2007). Recommendations for the management of the haematological and onco‐haematological aspects of Gaucher disease1. British Journal of Haematology. 138(6). 676–686. 66 indexed citations
18.
Halle, Pascale, Catherine Paillard, M. D’Incan, et al.. (2002). Successful Extracorporeal Photochemotherapy for Chronic Graft-Versus-Host Disease in Pediatric Patients. Journal of Hematotherapy & Stem Cell Research. 11(3). 501–512. 30 indexed citations
19.
Boiret, Nathalie, Justyna Kanold, Marc Fouassier, et al.. (2000). CFU-Mk Content of Immunoselected CD34 + Peripheral Blood Progenitor Cells, Evaluated with an Adapted Serum-Free Methylcellulose Assay, Is Predictive of Platelet Lineage Reconstitution in Children with Solid Tumors. Journal of Hematotherapy & Stem Cell Research. 9(4). 525–534. 10 indexed citations
20.
Straus, Walter L., Joshua J. Ofman, Catherine H. MacLean, et al.. (2000). Assessment of the proportion of gastrointestinal perforations, ulcers and bleeds (PUBS) attributable to NSAIDs. Gastroenterology. 118(4). A720–A720. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Kraft Breakdown of academic impact, for papers by Martin Champagne Breakdown of academic impact, for papers by Arnulf Pekrun Breakdown of academic impact, for papers by Kimberly Straley Breakdown of academic impact, for papers by Yoshio Kanayama Breakdown of academic impact, for papers by Robert Silasi‐Mansat Breakdown of academic impact, for papers by Matthew R. Warr Breakdown of academic impact, for papers by Eugenio Gallo Breakdown of academic impact, for papers by Leigh Samsel Breakdown of academic impact, for papers by Naoko Minegishi
Rankless by CCL
2026